MELVILLE, N.Y. -- Jan. 2, 2008--OSI Pharmaceuticals today announced that it intends to offer, subject to market conditions, a new issue of $150 million of Convertible Senior Subordinated Notes due ...

OSI Systems ( (OSIS)) has shared an announcement. On November 17, 2025, OSI Systems announced the pricing of its upsized $500 million convertible senior notes offering, increased from the initially ...

HAWTHORNE, Calif., November 18, 2025--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ: OSIS) (the "Company" or "OSI") today announced the pricing of its offering of $500 million aggregate principal amount ...

OSI Systems ( (OSIS)) has shared an update. On November 17, 2025, OSI Systems announced a proposed private offering of $400 million in convertible senior notes due 2031 to qualified institutional ...

Additionally, OSI Systems announced the pricing of $500 million in convertible senior notes due 2031, an increase from the previously announced $400 million offering. These notes carry a 0.50% ...

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ: OSIS) (the “Company” or “OSI”) today announced its intention to offer, subject to market and other conditions, $400 million aggregate ...

Entering a research deal with Structural GenomiX Inc. that's intended to speed up the testing of drug leads, OSI Pharmaceuticals Inc. separately agreed to issue $135 million in convertible notes in a ...

OSI Systems, Inc. (NASDAQ: OSIS) (the “Company” or “OSI”) today announced the pricing of its offering of $500 million aggregate principal amount of 0.50% convertible senior notes due 2031 (the “notes” ...